Our Services

Our experienced team of scientists and pharmaceutical specialists provide a flexible and comprehensive service to businesses on the following:

Pharmaceuticals

 

wafermine®

(sublingual ketamine wafer)

  • Being developed for the treatment of acute moderate to severe pain.
  • Effective alternative to opioids; has opioid-sparing effect
  • Completed end-of-Phase-2 with the US FDA

bnox®

(sublingual buprenorphine wafer)

  • Being developed for the treatment of moderate to severe pain
  • Buprenorphine is also a suitable substitute drug for opioid addiction

wafesil®

(sublingual sildenafil wafer)

  • For male erectile dysfunction
  • Registered for supply in Australia under AUST L 288496, 288497

silcap®

(sildenafil capsule)

  • For male erectile dysfunction
  • Registered for supply in Australia under AUST L 291996, 291999